We explored how plasma metabolites can help us diagnose chronic kidney disease (CKD) and IgA nephropathy (IgAN) early on. By analyzing blood samples using advanced techniques, we found that melatonin itself can identify early CKD with over 95% accuracy.
Additionally, combining melatonin with tryptophan achieved a remarkable 100% accuracy for CKD diagnoses. Indole-3-lactic acid also showed great potential in distinguishing IgAN in CKD patients, reaching over 85% accuracy for early IgAN diagnosis.
Read More
Melatonin improves MS-related functionsEffects of Melatonin Supplementation on Muscle Strength, Manual Dexterity, and Postural Balance in Patients Living with Multiple sclerosis - A Randomized Controlled Trial.
High relevance for MS management
We investigated how melatonin supplementation impacts motor skills and cognitive function in patients with multiple sclerosis. In a controlled trial, 27 participants were divided into a melatonin group and a placebo group for a 12-week period.
The results were promising: the melatonin group showed improvements in knee muscle strength, manual dexterity, and balance, alongside better mood and cognitive performance. This suggests that melatonin may be beneficial for enhancing quality of life in those managing multiple sclerosis symptoms.
Read More
Melatonin reduces inflammation and atrophyMelatonin Regulates Rheumatoid Synovial Fibroblasts-Related Inflammation: Implications for Pathological Skeletal Muscle Treatment.
High relevance for autoimmune research
We explored how melatonin affects rheumatoid arthritis-related muscle atrophy. By analyzing its anti-inflammatory properties, we found that melatonin can significantly decrease inflammation in rheumatoid synovial fibroblasts and enhance muscle cell growth.
Our research included the use of a collagen-induced arthritis mouse model, showing improvements in swelling and muscle strength after melatonin treatment. This study highlights melatonin’s potential in combating muscle atrophy and fostering muscle growth in autoimmune conditions like rheumatoid arthritis.
Read More
Melatonin shows promise in MS treatmentMelatonin synergistically potentiates the effect of methylprednisolone on reducing neuroinflammation in the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
High relevance in autoimmune research.
We investigated how melatonin may influence autoimmune disorders, specifically in a mouse model of multiple sclerosis. By combining melatonin with methylprednisolone, a common glucocorticoid treatment, we noticed a protective effect in reducing neuroinflammation. This combination therapy not only decreased harmful immune cells in the central nervous system but also shifted the immune response towards a more regulated state.
Notably, melatonin seems to improve the effects of methylprednisolone, suggesting it could be a promising complement in treating relapses of multiple sclerosis.
Read More
In our exploration of melatonin's potential in rheumatoid arthritis (RA) treatment, we utilized hyalurosomes within a collagen gel to enhance its therapeutic effects. The study involved both laboratory and animal testing, showing that melatonin encapsulated in these carriers significantly improved joint healing and cartilage repair in rats.
While traditional RA treatments often have limited effectiveness and side effects, our findings suggest that this innovative approach may offer a safer alternative. Importantly, no adverse interactions were found, indicating a promising future for melatonin in RA management.
Read More